Skip to main content

Applied BioSciences Retains the Emmes Group to Partner on Therapeutic Development Initiatives

By April 10, 2019News
applied-bioscience-emmes-logo.png

applied-bioscience-emmes-logo.pngApplied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical, testing and pet health industries, announced that is has retained the Emmes Group to assist with the development and execution of the Company’s partnership and technology licensing initiatives and strategies.

{iframe}https://upticknewswire.com/applied-biosciences-retains-the-emmes-group-to-partner-on-therapeutic-development-initiatives/{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.